Canada: Medical Marijuana In The Workplace: How The System Works

Medical marijuana in Canada has triggered a classic debate between those favouring its more liberal use to address medical problems, opposite those who believe greater legal access will accelerate the illegal, recreational use of cannabis. That debate appears to have been settled, at least in the courts, with the June 11, 2015 decision of the Supreme Court of Canada in the case of R. v. Smith.

It has been almost 5,000 years since the medical benefits of cannabis were first recorded in a Chinese pharmacology text. In the early 20th century, the drug became illegal in Canada; in the early 21st century, Parliament amended the Criminal Code and other legislation to permit highly-regulated uses of the drug for medical and therapeutic purposes.

Following the passage of the new Medical Marijuana Purposes Regulations (MMPRs) in April 2013, Canadians found themselves under a new regulatory regime for medical cannabis. The new model put a heavy emphasis on controlling distribution of medical cannabis by using approved producers as the de facto regulator of how the drug reaches individual users. Although not strictly a "medication", cannabis is now being prescribed to deal with a number of conditions such as arthritis, cancer treatment symptoms, chronic pain and sleeping disorders.

However, until last week the only legal method of consuming it in Canada for such purposes, was to smoke it. Smoking the drug, however, posed many barriers to effective use: many people don't like to smoke; most other people don't like it when others' smoke; the drug has a well-recognized aroma that is hard to ignore and, most seriously, smoking it is not always the best way to get the medicinal benefits. Indeed, ingested and applied forms of the drug may have better long term therapeutic effects.

Inevitably the law was challenged as a violation of personal security under the Charter of Rights and Freedoms. Freedoms can only be infringed if necessary, and only to the minimum degree possible. Listening to the Government's argument for limiting non-smoking uses versus the demand for freer use of alternative modes of ingesting the drug, the Court was plain:

... the evidence established no connection between the impugned restriction and attempts to curb the diversion of marihuana into the illegal market. We are left with a total disconnect between the limit on liberty and security of the person imposed by the prohibition and its object.

In the absence of any rational reason to prohibit non-smoking uses, the Supreme Court struck down the Criminal Code provisions in question. Thus, as of June 11, 2015, any medically effective form of ingestion is now legal. For employers, the task now is to understand who can use the drug and how workplaces may have to adjust to that reality.

How the System Works: Interview with Chris Murray, of Tweed Inc.

It has been difficult, in the din of competing arguments about medical marijuana, to get simple, straightforward information about the drug and how it is regulated. To cut through the noise, Gowlings went to a source – literally a source: one of the companies which is licensed in Canada to grow and distribute medical marijuana.

Chris Murray is the Director of Business & Medical Development for Tweed,1 a company licensed to grow and distibute medical marijuana. Murray's job is to provide information to the public, patients and medical practitioners about clinical uses of cannabis, approaches to treatment, and guidance on when cannabis is and isn't indicated. Murray is also tasked with providing guidance on how the marijuana regulatory system works. He agreed to answer a barrage of questions on the topic for this article.

Gowlings ("G"): Who can legally grow and sell medical marijuana in Canada today?

Murray ("M"): There are 18 companies licensed to grow and sell the drug. In addition, 7 more are licensed to grow it not to sell it to patients.

G: Where is it grown? Where is it processed into medical use forms?

M: Regulations (section 14 of the MMPR) require it to be grown indoors. Greenhouse or hydroponic. Our company, Tweed, has both.

Nobody can grow it outdoors – that prevents access to the plant and also limits seed migration.

G: How many forms of the drug are there, that can be prescribed?

M: We have over 30 strains to offer in the market. Distinctions: potency.

G: Can any physican prescribe the drug? What qualifies or disqualifies a physician from doing so?

M: In Canada, any doctor with an MD registered with a college can prescribe the drug, except those whose practice is restricted from dispensing narcotics.

G: If prescribed the drug, what legal permission does an individual require to obtain and possess it?

M: The patient gets a document from a doctor; this is akin to a prescription, but cannabis is not recognized as a medication, technically. The patient chooses a licensed producer, sends the prescription to the producer, fills in the paperwork and waits for it to be dispensed.

G: So the producer, the company selected by the patient, gets the prescription and then ships the product to the patient?

M: Yes. The producer acts as both the pharmacy and pharmaceutical company.

G: So what does the patient get?

M: She gets the product, of course. All the pertinent details are on the packaging. And the patient also gets a card with the information necessary to justify posession of the drug. She can provide that card to law enforcement if questioned.

G: Are individuals reporting problems with the police, in terms of possessing it?

M: No, the patients aren't reporting this as an issue.

G: What kind of limits, in terms of volume of the drug dispensed or the time a prescription applies, is common?

M: The prescription determines the number of grams the patient is allowed to get access to, per day. The average is 1 gram a day for a period of 6 months. However, there is a maximum amount we can ship.

G: Which is what?

M: A producer is allowed to ship at one time to one person, the lesser of 30 days' dosage or 150 grams. No shipment can ever exceed 150 grams, regardless of the prescribed dosage.

G: Let's talk about why marijuana is being prescribed.

M: First of all, what most people don't realize is cannabis isn't treatment, in the sense of addressing the cause a person's condition. It's like an Advil – it's a therapy, so it's used to manage the symptoms of conditions.

G: What's in cannabis that gives it any effect?

M: There are two active ingredients in the marijuana grown and distributed by approved companies: cannabinoids (CBD) and tetrahydrocannabinol (THC). The effects of CBD are medically hypothesized; the effects of THC are firmly established. Cannabis has these established effects:

  • It's an anti emetic (nausea supression),
  • It may suppress nerve inflammation
  • It reduces the symptoms of neuropathic pain
  • It causes a "euphoric" effect, which can relieve anxiety
  • For patients whose illnesses affect appetite, it stimulates appetite
  • The sedative effects are key for people with sleep disruption or disorders
  • It has also been shown to reduce seizure occurrence in some epileptic patients

G: To whom is it being most typically prescribed?

M: Patients with chronic neuropathic pain, or those whose cancer treatments produce terrible side effects, are among the people most often being directed to use medical marijuana.

G: How does medical marijuana compare to what people buy "on the street" for recreational use?

M: Street product usually contains other compounds. Medical marijuana that is properly grown, also provides patients of with laboratory tested levels of CBD and THC. For the most part illegal product is on the higher end of the THC potency spectrum 25% or more.

There are over 30 different strains of medical marijuana being produced by our company, Tweed. The key difference among the strains is the labeled potency of each active ingredient. Different strains are prescribed for different purposes.

G: A major concern about the drug is what you call its "euphoric" effect. What most people think of as "the high" from marijuana. Does the drug in its medical form, have similar or different effects than when used recreationally?

M: Yes, it has that effect, but it varies depending on the strain, the dosage and the user him or herself. The euphoric effect can be profoundly positive for a patient who has been suffering terrible symptoms due to chemotherapy, for example. There is also a euphoric effect with most products that effect neurotransmitters. It's important to remember the part of a sleeping pill that makes you sleep is considered "psychoactive".

G: But the user of medical marijuana may be impaired – their judgment, senses, etc may be altered by the drug while it is active in them?

M: Yes. But impairment is a subjective thing – people are affected differently by doses of any drug. And like any other drug, the initial impairment or sedative effect of marijuana is typically stronger, but is reduced as the person becomes accustomed to use.

G: What about the workplace implications of this? Does this come up among the patients who order their medical marijuana from your company?

M: Yes. A person comes in asking us to make a case for them to consume cannabis in the workplace. But where there is a requirement to have a sound mind and judgment, where an impairment would pose a risk to the person or others – like in heavy industry - and if a person is demonstrably impaired I would assume continuing to work may pose a risk and it's difficult to support the use of cannabis under normal cirmcumstances.

G: Many employers have policies that say that if someone is using an impairing substance, the person can't be working. What is your advice to employees who have been prescribed the drug, where there is some potential risk?

M: The drug may potentially affect performance. If there's a safety risk, they absolutely should not be at work.

But, we should remember that if someone has a blinding migraine or chronic neuropathic pain, that could be much more impairing than a low dose of any drug. We can't presume that a drug necessarily affects a person more than the medical problem they're suffering from.

G: But clearly we don't want people at work – or even travelling to work – if they're impaired by a drug.

M: That is absolutely right. As with any drug a person uses for medical purposes, that is absolutely true. As with any drug, we shouldn't let people work where the effect could endanger them or anyone else.

Murray recommends that those interested in the topic, visit the Health Canada website.


1. Disclosure: Tweed Inc. has in the past been a client of Gowlings

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
16 Jan 2018, Seminar, Birmingham, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

23 Jan 2018, Seminar, London, UK

Join Gowling WLG's pensions team as they explain some of the biggest challenges facing trustees and employers in the coming year and provide practical ways of dealing with them.

25 Jan 2018, Seminar, Birmingham, UK

2018 is set to be another big year in employment, with employers set to face new challenges and responsibilities. At our event, looking ahead to next year, we will be discussing four key issues you might face in 2018, providing useful tips and answering your questions.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions